Authors: Corpechot, C Carrat, F Bonnand, AM Poupon, RE Poupon, R

Citation: C. Corpechot et al., The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis, HEPATOLOGY, 32(6), 2000, pp. 1196-1199

Authors: Guechot, J Serfaty, L Bonnand, AM Chazouilleres, O Poupon, RE Poupon, R

Citation: J. Guechot et al., Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis, J HEPATOL, 32(3), 2000, pp. 447-452

Authors: Poupon, RE Bonnand, AM Queneau, PE Trepo, C Zarski, JP Vetter, D Raabe, JJ Thieffin, G Larrey, D Grange, JD Capron, JP Serfaty, L Chretien, Y Girardin, MFS Mathiex-Fortunet, H Zafrani, ES Guechot, J Beuers, U Paumgartner, G Poupon, R

Citation: Re. Poupon et al., Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferon, SC J GASTR, 35(6), 2000, pp. 642-649

Authors: Poupon, RE Bonnand, AM Chretien, Y Poupon, R

Citation: Re. Poupon et al., Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis, HEPATOLOGY, 29(6), 1999, pp. 1668-1671

Authors: Bonnand, AM Heathcote, EJ Lindor, KD Poupon, RE

Citation: Am. Bonnand et al., Clinical significance of serum bilirubin levels under ursodeoxycholic acidtherapy in patients with primary biliary cirrhosis, HEPATOLOGY, 29(1), 1999, pp. 39-43